📑 What This Document Is 📰

This is a Form 6-K, which is a filing submitted by a foreign private issuer (a company incorporated outside the United States) to the U.S. Securities and Exchange Commission (SEC). Think of it as Haleon's routine report to keep U.S. investors informed about its major activities and operational details. 👉 This specific filing announces details about the company's ongoing share repurchase plan, signaling a focus on returning value to shareholders.

🏢 Who Is Haleon? 💊

Haleon is a consumer healthcare company primarily focused on "better everyday health." Instead of selling a single product, Haleon manages a diverse portfolio of trusted health brands. 👉 Their business model relies on having a broad array of consumer-facing products, making them a large player across multiple health needs.

Haleon’s product portfolio is broken down into six major categories:

Oral Health
Vitamins, Minerals and Supplements (VMS)
Pain Relief
Respiratory Health
Digestive Health
Therapeutic Skin Health and Other

The company powers superior brands that are trusted globally, serving over one billion consumers. These well-known brands include: Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.

🔄 The Share Buyback Announcement 🛒

The central news in this report is that Haleon conducted a series of share purchases, known as a buyback program. Companies buy their own shares from the open market and then cancel them. This reduces the total number of outstanding shares, which generally makes the company look more valuable to the remaining shares.

The company announced the purchase of a total of 8,740,351 ordinary shares of £0.01 each for cancellation. This activity falls under the buyback program that was originally announced on 12 March 2026.

📈 Daily Buyback Transactions (April 13-17, 2026) 📉

The filing provides highly detailed, day-by-day metrics showing the volume and pricing of the shares purchased across three different exchanges (London Stock Exchange, CBOE, and Aquis). This granular data lets investors track the execution and average cost of the program.

Here is a summary of the shares purchased across five days:

April 13, 2026: The company purchased 671,220 shares. The Volume Weighted Average Price (VWAP) paid per share was 362.4249p.
April 14, 2026: The company bought 1,076,661 shares, with a VWAP of 357.3007p.
April 15, 2026: The company purchased 1,035,952 shares, with a VWAP of 354.9721p.
April 16, 2026: The company acquired 683,227 shares, with a VWAP of 353.2067p.
April 17, 2026: The company purchased 332,308 shares, with a VWAP of 355.9556p.

👉 Why this matters: Tracking the VWAP shows how efficiently the company is buying shares. Over these five days, the average buying price remained tightly clustered, indicating the buyback program was executed consistently.

🏦 Impact on Share Capital 🔢

Every time a company buys and cancels its own shares, its legal capital structure changes. The filing reports the post-buyback status of the company's capital.

After the transaction, the key figures related to Haleon’s shares are:

Registered Share Capital: 8,911,083,689 ordinary shares of £0.01 each.
Treasury Shares: 12,320,645 shares are held by the company as treasury stock.
Voting Shares: The number of ordinary shares with voting rights stands at 8,898,763,044.

👉 Why this matters: The reduction in voting shares (the most precise figure cited) is critical because shareholders use this number to understand their ownership interest and compliance requirements under regulations like the FCA's Disclosure Guidance and Transparency Rules.

🧑‍💼 Signatures and Legal Disclaimers 📜

A 6-K filing always contains legal boilerplate that protects the company and gives specific instructions. This section confirms the authority and compliance status of the filing.

Attestation: The report was signed by Amanda Mellor, the Company Secretary, on April 20, 2026.
Disclaimer: The document explicitly states that the announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction. This is standard protective language to prevent misunderstandings about the buyback.

📞 Investor Relations and Enquiries 📧

For investors and media looking for more information, the filing provided several dedicated contacts. These channels are crucial for following up on the company's financial activities and corporate news.

Investor Media Contacts:

Jo Russell: +44 7787 392441
Zoë Bird: +44 7736 746167
Rakesh Patel: +44 7552 484646
Victoria Durman: +44 7894 505730

Email Addresses:

🧠 The Analogy

A share buyback program is like a major sports team deciding to buy back a batch of its own tickets from the secondary market. By taking these tickets off sale and retiring them, the team is essentially making its remaining game-day experience (the company) seem more exclusive and more valuable to the people who still hold tickets (the remaining shareholders).

🧩 Final Takeaway

Haleon actively executed a share buyback program in April 2026, buying over 8.7 million shares. This consistent action reduces outstanding shares, increasing the value per share and signaling management's confidence in the company's future worth.

Haleon completes share buyback program, reduces outstanding shares significantly